Expression of TGF-beta mRNA Isoforms in Human Breast Cancer
Author Information
Author(s): J. MacCallum, J.M.S. Bartlett, A.M. Thompson, J.C. Keen, J.M. Dixon, W.R. Miller
Primary Institution: University Department of Surgery, Edinburgh Royal Infirmary
Hypothesis
The study aims to examine the expression of mRNA for the three different isoforms of TGF-beta in a series of human breast cancers.
Conclusion
Most breast cancers express mRNA for at least one isoform of TGF-beta, with significant associations between isoform expression and lymph node status.
Supporting Evidence
- 45 out of 50 tumors expressed TGF-beta1 mRNA.
- 39 out of 50 tumors expressed TGF-beta2 mRNA.
- 47 out of 50 tumors expressed TGF-beta3 mRNA.
- 37 tumors expressed all three TGF-beta isoforms.
- Significant association between expression of all three isoforms and lymph node involvement.
Takeaway
The study found that many breast cancer tumors have different types of TGF-beta messages, which might be linked to whether the cancer has spread to lymph nodes.
Methodology
RNAse protection assay was used to determine the expression of TGF-beta mRNA isoforms in tumor samples.
Limitations
The relatively small number of tumors examined precluded detailed analysis between expression and other clinical parameters.
Participant Demographics
Patients aged 41-91 years with histologically proven primary breast cancer.
Statistical Information
P-Value
0.025
Statistical Significance
p=0.025
Want to read the original?
Access the complete publication on the publisher's website